Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Features

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

L.A. McKeown

December 12, 2019

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

Todd Neale

October 14, 2019

Presentation TCT 2019

TCT 117: Novel optical coherence tomography classification of intravascular lesions in patients with chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty.

Presenter: Stanislaw Jankiewicz

September 25, 2019

News Daily News

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

Caitlin E. Cox

September 20, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

FDA Gives Eagerly Awaited Update on Mortality With Paclitaxel-Coated Devices in PAD

Todd Neale

August 07, 2019

News Daily News

Multiple Passes During Stroke Thrombectomy Ups Risk of Blood-Brain Barrier Disruption

Alison Palkhivala

July 05, 2019

News Daily News

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

L.A. McKeown

June 10, 2019

News Daily News

OVER Trial: Long-term Mortality Similar After Endovascular and Open AAA Repair

Todd Neale

May 30, 2019

News Conference News SCAI 2019

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

Yael L. Maxwell

May 21, 2019

News Daily News

FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD

L.A. McKeown

March 15, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2019

Caitlin E. Cox

January 31, 2019

News Daily News

AAA Rupture Rate in England Supports Current Thresholds for Surveillance, Intervention—With Some Caveats

Shelley Wood

January 21, 2019

Advertisement

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

FDA Gives Rivaroxaban Another VTE-Related Indication

TCT 117: Novel optical coherence tomography classification of intravascular lesions in patients with chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty.

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

FDA Gives Eagerly Awaited Update on Mortality With Paclitaxel-Coated Devices in PAD

Multiple Passes During Stroke Thrombectomy Ups Risk of Blood-Brain Barrier Disruption

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

OVER Trial: Long-term Mortality Similar After Endovascular and Open AAA Repair

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD

TCTMD’s Top 10 Most Popular Stories for January 2019

AAA Rupture Rate in England Supports Current Thresholds for Surveillance, Intervention—With Some Caveats

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content